1. 1. Ghoncheh M, Pournamdar Z, Salehiniya H (2016) Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev, 17(3): 43-46. [DOI:10.7314/APJCP.2016.17.S3.43] [PMID]

2. Leong SPL, Shen ZZ, Liu TJ, et al. (2013) Is breast cancer the same disease in Asian and Western countries? World J Surg, 34(10): 2308-2324. [DOI:10.1007/s00268-010-0683-1] [PMID] []

3. Hortobagyi GN, de la Garza Salazar J, Pritchard K, et al. (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6(5): 391-401. [DOI:10.3816/CBC.2005.n.043] [PMID]

4. Mahshid J and Arbabi F (2005) Cutaneous complication after electron beam therapy in breast cancer. J R Med Sci, 10(6): 368-370.

5. Tobler M and Leavitt DD (1996) Design and production of wax compensators for electron treatments of the chest wall. Med Dosim, 21(4): 199-206. [DOI:10.1016/S0958-3947(96)00126-4]

6. Levitt SH (2006) Technical basis of radiation therapy. Practical clinical applications. 4th ed. Springer, Berlin, Germany.

7. Overgaard M, Jensen MB, Overgaard J, et al. (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet, 353(9165): 1641-1648. [DOI:10.1016/S0140-6736(98)09201-0]

8. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J (2006) Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol, 24(15): 2268-2275. [DOI:10.1200/JCO.2005.02.8738] [PMID]

9. Ragaz J, Olivotto IA, Spinelli JJ, et al. (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst, 97(2): 116-126. [DOI:10.1093/jnci/djh297] [PMID]

10. EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 383(9935): 2127-2135. [DOI:10.1016/S0140-6736(14)60488-8]

11. Poortmans PM, Collette S, Kirkove C, et al. (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med, 373(4): 317-327. [DOI:10.1056/NEJMoa1415369] [PMID]

12. Whelan TJ, Olivotto IA, Parulekar WR, et al. (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med, 373(4): 307-316. [DOI:10.1056/NEJMoa1415340] [PMID] []

13. Akın M, Ergen A, Unal A, Bese N (2014) Irradiation doses on thyroid gland during the postoperative irradiation for breast cancer. J Cancer Res Ther, 10(4): 942-944. [DOI:10.4103/0973-1482.137991] [PMID]

14. Sethi RA, No HS, Jozsef G, et al. (2012) Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position. Radiother Oncol, 102(1): 74-81. [DOI:10.1016/j.radonc.2011.09.008] [PMID]

15. Richter JE and Castell DO (2011) The Esophagus 6e. Chichester, England: Wiley-Blackwell.

16. Dumane VA, Bakst R, Green S (2018) Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT. PLoS One, 13(10): e0205770. [DOI:10.1371/journal.pone.0205770] [PMID] []

17. Taylor C, Correa C, Duane FK, et al. (2017) Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol, 35(15): 1641-1649. [DOI:10.1200/JCO.2016.72.0722] [PMID] []

18. Darby SC, Ewertz M, McGale P, et al. (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med, 368(11): 987-998. [DOI:10.1056/NEJMoa1209825] [PMID]

19. Journy N, Schonfeld SJ, Hauptmann M, et al. (2020) Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer. Radiother Oncol, 151: 33-39. [DOI:10.1016/j.radonc.2020.07.022] [PMID]

20. Duane FK, Kerr A, Wang Z, et al. (2021) Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020. Radiother Oncol, 164: 261-7. [DOI:10.1016/j.radonc.2021.09.032] [PMID]

21. Clarke M, Collins R, Darby S, et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet, 366(9503): 2087-2106. [DOI:10.1016/S0140-6736(05)67887-7] [PMID]

22. Sharma DS, Animesh, Deshpande SS, et al. (2006) Peripheral dose from uniform dynamic multileaf collimation fields: implications for sliding window intensity-modulated radiotherapy. Br J Radiol, 79(940): 331-335. [DOI:10.1259/bjr/16208090] [PMID]

23. Herbert CE, Ebert MA, Joseph DJ (2003) Feasible measurement errors when undertaking in vivo dosimetry during external beam radiotherapy of the breast. Med Dosim, 28(1): 45-48. [DOI:10.1016/S0958-3947(02)00241-8]

24. Siji CT, Musthafa MM, Ganapathi RR, et al. (2015) Out-of-field photon dosimetry study between 3-D conformal and intensity modulated radiation therapy in the management of prostate cancer. Int J Radiat Res, 13(2): 127-134.

25. Akpochafor MO, Adeneye SO, Habeebu MY, et al. (2019) Organ dose measurement in computed tomography using thermoluminescence dosimeter in locally developed phantoms. Iran J Med Phys, 16(2): 126-132.

26. Huang JY, Followill DS, Wang XA, Kry SF (2013) Accuracy and sources of error of out-of field dose calculations by a commercial treatment planning system for intensity-modulated radiation therapy treatments. J Appl Clin Med Phys, 14(2): 186-197. [DOI:10.1120/jacmp.v14i2.4139] [PMID] []

27. West K, Schneider M, Wright C, et al. (2020) Radiation-induced oesophagitis in breast cancer: Factors influencing onset and severity for patients receiving supraclavicular nodal irradiation. J Med Imaging Radiat Oncol, 64(1): 113-119. [DOI:10.1111/1754-9485.12943] [PMID]

28. Lonski P, Kron T, Taylor M, et al. (2018) Assessment of leakage dose in vivo in patients undergoing radiotherapy for breast cancer. Phys Imaging Radiat Oncol, 5: 97-101. [DOI:10.1016/j.phro.2018.03.004] [PMID] []

29. Nikoofar A, Hoseinpour Z, Rabi Mahdavi S, et al. (2015) High-dose-rate (192)Ir brachytherapy dose verification: A phantom study. Iran J Cancer Prev, 8(3): e2330. [DOI:10.17795/ijcp2330]

30. Taylor ML and Kron T (2011) Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy. J Med Phys, 36(2): 59-71. [DOI:10.4103/0971-6203.79686] [PMID] []

31. Lonski P, Taylor ML, Hackworth W, et al. (2014) In-vivo verification of radiation dose delivered to healthy tissue during radiotherapy for breast cancer. Journal of Physics, 489(1): 012015. [DOI:10.1088/1742-6596/489/1/012015]

32. Soleymanifard S, Aledavood SA, Noghreiyan AV, et al. (2016) In vivo skin dose measurement in breast conformal radiotherapy. Contemp Oncol (Pozn), 20(2): 137-140. [DOI:10.5114/wo.2015.54396] [PMID] []

33. Abdemanafi M, Tavakoli MB, Akhavan A, Abedi I (2020) Evaluation of the lung dose in three-dimensional conformal radiation therapy of left-sided breast cancer: A phantom study. J Med Signals Sens, 10(1): 48-52. [DOI:10.4103/jmss.JMSS_1_19] [PMID] []

34. Davidson SE, Ibbott GS, Prado KL, et al. (2007) Accuracy of two heterogeneity dose calculation algorithms for IMRT in treatment plans designed using an anthropomorphic thorax phantom: Heterogeneity dose calculation algorithms accuracy using anthropomorphic phantom. Med Phys, 34(5): 1850-1857. [DOI:10.1118/1.2727789] [PMID]

35. Howell RM, Scarboro SB, Kry SF, Yaldo DZ (2010) Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys Med Biol, 55(23): 6999-7008. [DOI:10.1088/0031-9155/55/23/S03] [PMID] []

36. Kowalik A, Konstanty E, Piotrowski T, et al. (2019) Calculation and measurement of doses in the surface layers of a phantom when using Tomotherapy. Rep Pract Oncol Radiother, 24(2): 251-262. [DOI:10.1016/j.rpor.2018.11.006] [PMID] []

37. Kaderka R, Schardt D, Durante M, et al. (2012) Out-of-field dose measurements in a water phantom using different radiotherapy modalities. Phys Med Biol, 57(16): 5059-5074. [DOI:10.1088/0031-9155/57/16/5059] [PMID]